Vertex Pharmaceuticals Corporation

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

Connections from

Founded Date: 1989-01-01
Technology: Cancer
Investor Type: Company
Funding Status: IPO
Total Funding: 656200000.0
Employee Number: 1001-5000
Headquarters: Boston, Massachusetts, United States
Last Funding Date: 2022-05-17
Investors Number: 9.0
Last Funding Type: Post-IPO Equity
Estimated Revenue: $500M to $1B
Investment Stage: N/A
Acquisitions Number: Made Acquisitions
Number Of Exists: 2
Industry: Pharma